Alexion is a global biopharmaceutical company focused on serving patients with severe and rare disorders through the innovation, development and commercialization of life-transforming therapeutic products. Their goal to deliver medical breakthroughs where none currently exist is driven by the knowledge that people’s lives depend on their work.
myelife. my hope. is a glimpse into the human spirit. The stories these patients share leaves a powerful and lasting imprint and creates a unique connection for the viewer. The community will benefit greatly from the powerful impression myelife. my hope. will leave and encourages all viewers to look beyond the diagnosis to the patient.
Vanessa Procter, Executive Director, Global Government Affairs, Alexion Pharmaceuticals, Inc.